The treatment of Cervical Dysplasia & Glaucoma with vitamins

Cervical Dysplasia and Glaucoma: Mitamins custom make quality formulas for the treatment of Cervical Dysplasia & Glaucoma with vitamins. A Cervical Dysplasia & Glaucoma formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cervical Dysplasia and Glaucoma

  • Amount Per Serving
    % DV
    Vitamin A
    10000
    IU
    200%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    200
    IU
    667%
    Folate
    400
    mcg
    100%
    Vitamin B12
    125
    mcg
    2083%
    Zinc
    10
    mg
    67%
    Alpha Lipoic Acid
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lycopene
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Green Tea Extract
    600
    mg
    *
    L-Arginine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cervical Dysplasia and Glaucoma
Serving Size:4-5

Cervical Dysplasia and Glaucoma Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Early Allergy Diagnoses Are Associated With A Reduced Risk Of Acute Lymphoblastic Leukaemia
Children who receive a definite diagnosis of allergy in early life have a 20% reduced risk of developing acute lymphoblastic leukaemia (ALL), according to results from the first large-scale study to use contemporaneously collected primary care data to examine the association between childhood leukaemia and preceding allergy.
Nastech Pharmaceutical Company Announces Initiation Of Phase 2 Clinical Trial For PYY3 36 Nasal Spray To Treat Obesity
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced the start of a Phase 2 clinical trial evaluating the Company's PYY3-36 Nasal Spray in obese patients. The study will enroll approximately 500 obese patients for a six-month, randomized, placebo-controlled dose ranging study with weight loss as the primary endpoint.
This information concerning the support of Cervical Dysplasia and Glaucoma treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments